Manufacturer record
Hab Pharmaceuticals & Research Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Hab Pharmaceuticals & Research Limited (Uttarakhand) were declared Not of Standard Quality between May 2019 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Hab Pharmaceuticals & Research Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Tramadol Capsules IP 5 mg | 1686-06Mfg 2025-08 · Exp 2027-07 | Uniformity of WeightUniformity of weight/content | SDTL, VijayawadaState lab | Feb 2026 |
| Voglibose Tablets IP 0.2mg | 1121-27Mfg 2022-10 · Exp 2024-09 | Test for AssayAssay | CDTL MumbaiState lab | Mar 2023 |
| Doxofylline Tablets IP 400 mg (DOXOSIGN TABLETS) | 994-09Mfg 2021-06 · Exp 2024-05 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | May 2022 |
| Amlodipine Besylate and Atenolol Tablets (CARDINOL PLUS TABLETS) | 1154-12Mfg 2021-05 · Exp 2024-04 | Assay of AmlodipineAssay | RDTL ChandigarhState lab | Nov 2021 |
| OXYTOCIN INJECTION IP | 1021-01Mfg 2019-05 · Exp 2022-04 | Assay of Oxytocin ActivityAssay | RDTL ChandigarhState lab | Sep 2021 |
| Methylergometrin e Tablets IP 0.125 mg | 1166-01Mfg 2020-05 · Exp 2022-04 | AssayAssay | RDTL GuwahatiCDSCO lab | Jul 2021 |
| CARDINOL-50 (Atenolol Tablets I.P. 50 mg) | 1091-05Mfg 2020-02 · Exp 2023-01 | DisintegrationDisintegration | CDL KolkataCDSCO lab | May 2021 |
| Atorvastatin Tablets IP 20mg | 968-01Mfg 2019-01 · Exp 2020-12 | AssayAssay | CDTL MumbaiCDSCO lab | Sep 2019 |
| Betahistine Tablets I.P. 16 mg | 767-02Mfg 2017-07 · Exp 2019-12 | Assay & Uniformity of ContentAssay | CDL KolkataCDSCO lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.